Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation

The study compares the efficacy and safety of two medications - mirabegron and oxybutynin - in patients after a surgical procedure called posterior urethral valve ablation. This is a comparative clinical trial that evaluates how these drugs work in treating bladder symptoms following this type of surgery. Oxybutynin is a traditional medication used to treat overactive bladder, while mirabegron represents a newer approach. The study examines which of these two medications is more effective and safer for patients in this specific clinical situation. Results from such comparative studies help physicians select the most appropriate treatment for individual patients.